XTNT - i didn't like the chart several days ago and so sold my 6k shares at 0.57 (bought at 0.53), but then i re-bought those shares at 0.60 on the retrace Thursday after the great earnings report, and i just missed getting more at 0.55 on Friday. I may have to up my bid.
I like this one a lot going forward. Certainly the analysts like it.
12/8/2016 Maxim Group Initiated Coverage Buy $2.00
11/30/2016 Aegis Initiated Coverage Buy $3.50
8/4/2016 HC Wainwright Reiterated Rating Buy
3/17/2016 Brean Capital Reiterated Rating Buy $10.00
I'd like to see Brean Cap reiterate a buy for 2017 with a realistic price-target. A lot of folks follow Brean Capital's analyst reports on biotechs.
Short-term, technically, let's see if XTNT holds its 50dma on the daily chart. If it breaches that, i'll buy again in low 0.50s.
I think this one will enjoy a rosy 2017, especially if/when the biotech sector bounces back.
